Skip to main content
Isofol Medical logo

Isofol Medical — Investor Relations & Filings

Ticker · ISOFOL ISIN · SE0009581051 LEI · 549300MCXYAHG7VBHX75 ST Professional, scientific and technical activities
Open in API
Filings indexed 208 across all filing types
Latest filing 2023-02-13 AGM Information
Country SE Sweden
Listing ST ISOFOL

About Isofol Medical

https://isofolmedical.com/

Isofol Medical is a clinical-stage biotechnology company dedicated to improving treatments for severe forms of cancer. The company's primary focus is the development of its lead drug candidate, arfolitixorin. This next-generation, folate-based therapy is designed to enhance the efficacy of standard cancer treatments, such as chemotherapy. Arfolitixorin is the active metabolite of commonly used folate-based drugs, potentially offering a therapeutic benefit to a broader patient population by bypassing complex metabolic activation steps. The company's goal is to help more patients respond better to their treatment, thereby improving their prognosis.

Recent filings

Filing Released Lang Actions
Kommuniké från extra bolagsstämma i Isofol Medical AB (publ) den 13 februari 2023
AGM Information Classification · 99% confidence The document is titled "Kommuniké från extra bolagsstämma i Isofol Medical AB (publ) den 13 februari 2023" (Communiqué from the Extraordinary General Meeting in Isofol Medical AB (publ) on February 13, 2023). It explicitly details the decisions made by shareholders at this meeting, such as the rejection of a proposed extraordinary dividend and a voluntary liquidation proposal. This content directly relates to the outcomes and proceedings of a shareholder meeting. The most appropriate classification among the provided options is AGM-R (AGM Information), as an Extraordinary General Meeting (EGM) shares the same fundamental nature as an AGM regarding shareholder decisions and resulting communications, even though the code is AGM-R.
2023-02-13 Swedish
Kallelse till extra bolagsstämma i Isofol Medical AB (publ) den 28 februari 2023
AGM Information Classification · 99% confidence The document is titled "Kallelse till extra bolagsstämma i Isofol Medical AB (publ) den 28 februari 2023" (Notice of Extraordinary General Meeting in Isofol Medical AB (publ) on February 28, 2023). It details the date, time, location, registration procedures, and the proposed agenda for an Extraordinary General Meeting (EGM). The agenda includes items typically found in a meeting notice, such as electing the chairman, determining the number of board members, setting remuneration, and electing board members/chairman. This content directly corresponds to the purpose of calling a general meeting and soliciting shareholder input/votes, which aligns best with the definition of materials related to a General Meeting, specifically an Extraordinary one. Since the document is the formal notice/call for the meeting, and it includes proposals for voting (like board elections), it is most accurately classified as related to the Annual General Meeting process, even though it is an 'Extraordinary' one. The closest fit among the provided codes is AGM-R (AGM Information), as it pertains to the meeting itself and the materials presented for shareholder action.
2023-02-03 Swedish
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for an entity ('Futur Pension Holding AB') in another company ('Isofol Medical AB (publ)'). It explicitly states the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights (3.38105%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2023-02-03 English
Isofol has obtained a request to call for an extraordinary general meeting
Board/Management Information Classification · 99% confidence The document explicitly states that Isofol Medical AB has 'obtained a request to call for an extraordinary general meeting to elect a new board of directors.' This announcement concerns the calling of a general meeting (EGM) and the election of directors, which falls under the scope of shareholder meetings and related governance actions. While it mentions electing a new board (MANG), the primary action announced is the calling of the meeting itself. Since the text is a short press release announcing a future event (the EGM) and not the results (DVA) or the presentation materials (AGM-R), it is best classified as a general regulatory announcement or a notice related to a meeting. Given the options, 'AGM-R' covers general meeting information, and since this is a notice about calling an EGM, it is the closest fit among the specific meeting-related codes, although 'RNS' (Regulatory Filings) is also a strong candidate if the focus is purely on the announcement mechanism. However, because the core subject is the calling of a general meeting, AGM-R is selected as the most specific relevant category for meeting announcements, even if it's an EGM rather than an AGM.
2023-01-30 English
Isofol har erhållit en begäran om att kalla till extra bolagsstämma
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Isofol Medical AB has received a request from shareholders (representing at least 10% minority) to convene an Extraordinary General Meeting (EGM) specifically for the purpose of electing a new board of directors. This directly relates to changes in the company's board structure and governance, which is covered under Board/Management Information (MANG) or potentially Governance Information (CGR). However, the core event is the request for a meeting to elect a new board, which is a management/board change event. Since the document is an announcement about a meeting to elect a new board, it fits best under Board/Management Information (MANG). It is not a formal AGM presentation (AGM-R), a formal voting result (DVA), or a general regulatory filing (RNS), as it concerns a specific management/governance action.
2023-01-30 Swedish
Kallelse till extra bolagsstämma i Isofol Medical AB (publ) den 13 februari 2023
AGM Information Classification · 98% confidence The document is titled "Kallelse till extra bolagsstämma i Isofol Medical AB (publ) den 13 februari 2023" (Notice of Extraordinary General Meeting in Isofol Medical AB (publ) on February 13, 2023). It details the procedures for attending the meeting, voting, and presents proposals for the agenda, specifically concerning a proposed dividend and the liquidation of the company. This content directly relates to the formal process and materials surrounding a shareholder meeting, which aligns perfectly with the definition of AGM Information (AGM-R) or potentially Proxy Solicitation & Information Statement (PSI) if it were soliciting votes for a routine matter. However, since it is a formal 'Kallelse' (Notice) for an Extraordinary General Meeting (EGM) detailing the agenda and proposals, AGM-R is the most appropriate classification for the meeting notice itself, even though it discusses liquidation (which might also trigger other filings later). Given the explicit reference to the 'bolagsstämma' (general meeting) and the nature of the document as the official notice/call, AGM-R is selected.
2023-01-19 Swedish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.